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Methods
Healthy individuals, greater than 18 years of age, with a known melanoma were recruited from
Washington University clinics. Each patient was evaluated by the principal investigator, Dr. Cornelius,
prior to study involvement. Photoacoustic tomography (PAT) was performed prior to the scheduled
excision of their melanoma. The excision was not delayed in order to perform PAT imaging of the
melanoma. Prior to participation, patients were consented via the IRB approved consent forms (IRB
ID#: 201410125). Ten patients were recruited and a total of thirteen lesions were imaged. Benefits
and risks of the study were explained to the patients in detail and written consent was obtained. We
performed PAT imaging of the melanomas using our handheld probe followed by an excision to
determine the BD of each melanoma. Of the thirteen lesions that were imaged, six cases presented
after an initial incisional biopsy, providing a provisional BD (pBD) prior to PAT imaging (see
Supplementary Tables S1 & S2 online). Following imaging and histologic examination, we determined
that one lesion was comprised entirely of melanophages with no tumor cells, and another amelanotic
tumor extended to a depth (>10 mm) that was beyond the maximum imaging capacity of the PAT
probe, although the shallower part of the melanoma can be still imaged. A third patient who
presented with widely metastatic disease received systemic therapy at an outside institution prior to
wide local excision of his primary lesion. Thus, we excluded these three cases in our final data analysis.
An overview of the ten cases in the tables below includes five melanomas without the partial biopsies
depths and five melanomas with partial biopsy depths.
To image the melanin-containing lesion, a handheld device was used (total skin contact surface area
1.25” x 0.5”). The determination of tumor depth and width by PAT at 680 nm wavelength depends
upon the presence of melanin in the tumor, where blood has the lowest absorption. From the image,
we were able to determine tumor depth or thickness (PA depth) as well as construct a 3D rendering of
the tumor. These images along the z-x plane were then compared to the histological section at the
same location (marked at the time of excision). The PAT measurement was adjusted by a factor of
0.88 to account for ex-vivo tissue fixation and processing (Winsor, 1994) and this is indicated as
corrected (cPA) depth.
To increase imaging depth and detection reliability for highly pigmented lesions, skin was illuminated
outside the pigmented part with high laser energy. Precaution was taken to guarantee that laser
fluence at skin surface did not exceed American National Standards Institute (ANSI) safety limits. The
optical fluence on the skin surface is approximately 10 mJ/cm2, which is less than the safety limit set
by the ANSI (20 mJ/cm2) at this wavelength.
Maximum laser delivered pulse energy at full laser power was below 80 mJ at 650 nm, and light
uniformly illuminates the skin area 2 cm x 2 cm which is within ANSI safety limits for skin exposure to
laser light. Light delivery system was shielded to avoid eye exposure. Operator and patient used
approved safety glasses with OD 6 at laser wavelengths. A DAQ module, which is in contact with
patient, was installed in a personal computer and powered from it. Appropriate eye protection will be
worn by patients and technicians at all times.
After the patient was deemed appropriate for imaging (L.A.C.), the patient presented for imaging, and
at least two researchers consistently evaluated each patient (Y.Z and S.V.T.) to determine the deepest
portion with in vivo measurement by PAT. These measurements were stored in a secure database.
Surgical excision was then performed normally, as what is considered the standard of care. A
dermatopathologist, (I.R.) blinded to the PAT measurement, provided the Breslow’s depth after
excision. These measurements were then compared to evaluate the accuracy of the PAT depth to the
Breslow’s depth and if provided initially, the partial biopsy depth (see Supplementary Tables S1 & S2
online).
Statistical analysis
Two important parameters are calculated based on the collected data, mean absolute error
(MAE) and the coefficient of determination (R2). For all the ten cutaneous melanoma metastasis
PAT depths (cPA), the MAE is calculated as
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where i is the patient index, fi is the cPA from ith patient, and yi is the excisional biopsy depth
from ith patient. In total, we have data from 10 patients used for calculation.
The formula used for R2 calculation is as follows:
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where f is the averaged value of cPA from all the ten measurements. For the five cases used
for comparing cPA and incisional biopsy, the calculation for the MAE is similar just with different
number of cases. The smaller MAE from PAT measurements than from the incisional biopsy
indicates that PAT is more accurate in our study.
We also calculated the test confidence level in comparing the accuracy between PAT and
incisional biopsy measurements. Our case can be treated as a two-sample t test, in which the
test value can be calculated as:
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where n is the number of samples in each group, X1 is the absolute difference between PAT
measurement and excisional biopsy, X2 is the absolute difference between incisional and
excisional biopsy, 1X is the mean value for all X1, and 2X is the mean value for all X2.
Substituting out data (n = 5, 1X = 0.14, 2X = 0.21,  21X = 0.1001,  21)( X = 0.4409,  22X =
0.2046,  22 )( X = 1.2544), we have t(8) = -1.3723. For one-sided test, our result is close to
student’s t distribution value (-1.397) with 8 degrees of freedom and significant level of 0.1.
Although our sample size is small, we still achieved relative good confidence level. We will
perform more experiments to increase our confidence level in the future.
Photoacoustic tomography
Photoacoustic tomography (PAT) is a two-dimensional or three-dimensional imaging modality
based on optical excitation and acoustic detection. The discovery of its underline principle,
photoacoustic effect, can be traced back to 1880 by Alexander Bell. In PAT, usually a short
pulsed laser illuminates the target. Following the absorption of the laser pulse, an initial
temperature rise will generate an initial pressure rise based on the photoacoustic effect. The
pressure rise will then propagate as an ultrasonic wave and finally get detected by a single
ultrasonic transducer or a transducer array. On one hand, because PAT is based on optical
absorption contrast, it has detected a variety of absorbers, including melanin, which is the main
component of melanoma. On the other hand, because PAT is based on acoustic detection, it can
image deep biological structures with high spatial resolution. Thus, PAT has successfully imaged
melanoma in mice in vivo with thickness more than 7 mm.
Based on different imaging formation mechanism, PAT can be divided into point-scanning-based
photoacoustic microscopy and reconstruction-based photoacoustic computed tomography
(PACT). In our melanoma study, we used a PACT system based on a linear-array (one-
dimensional) probe. The basic parameters of this probe are introduced in the main text. The
elevational direction is defined as the direction perpendicular to the probe, the lateral direction
is the direction along the probe, and the axial direction is along the depth direction. The
resolution definitions are different along different directions. The elevational and lateral
resolutions, decided by the numerical aperture (NA) of the probe as well as the center acoustic
wavelength (λ) of the probe, can be estimated by 0.72λ/NA. The axial resolution, dependent on
the frequency bandwidth (Δf) of the probe and the speed of sound (c) in soft tissue, is given by
0.88c/Δf. Based on the probe parameters described in the manuscript, the resolutions can be
calculated.
Supplementary Table S1 online: Photoacoustic imaging on non-partially biopsied
melanomas. cPA measurement is the corrected Photoacoustic measurement of the
melanoma; BD is the final Breslow’s depth after excision of the entire melanoma.
Age Race Gender Melanoma
Location
PA
measurement
cPAdepth
Final
Pathology
BD= Breslow’s
depth
59 White Male Left leg
(lateral)
1.52 mm 1.67 mm
59 White Male Left leg
(medial)
1.20 mm 1.73 mm
56 White Female
Left calf 5.50 mm 5.00 mm
70 White Male Right leg
(medial)
1.00 mm 0.96 mm
70 White Male Right leg
(lateral)
1.20 mm 1.28 mm
Age Race Gender Melanoma
Location
Partial
biopsy
(pBD)
PA
measurement
cPAdepth
Final
Pathology
BD= Breslow’s
depth
78 White Male Left temple 0.55 mm 0.40 mm 0.30 mm
36 White Female Left ankle 0.51 mm 0.80 mm 0.80 mm
97 White Female Left calf 0.24 mm 0.32 mm 0.35 mm
53 White Female Right foot 0.48 mm 0.56 mm 0.78 mm
53 White Female Left arm 0.30 mm 0.53 mm 0.18 mm
Supplementary Table S2 online: Photoacoustic imaging on partially biopsied primary
melanomas. pBD = depth of partial biopsy; cPAmeasurement is the corrected
Photoacoustic measurement of the melanoma; BD is the final Breslow’s depth after excision
of the entire melanoma.

